Successfully delivering, phase I to phase III, full service global clinical trials
Early Access Programs
Our Early Access Programs deliver potentially lifesaving treatments to patients around the world
We provide a unique, combined approach to Clinical Development, Early Access Programs and Clinical Trial Supply. Our expert teams work seamlessly across our divisions, where they continuously use their experience and knowledge to plan, develop and execute projects to exceptionally high standards.
We build long-term, mutually beneficial partnerships. We listen carefully to what you tell us and share our insight to enhance results and deliver success. We are innovative but realistic in our recommendations, meeting your objectives while staying true to your culture.
At Bionical Emas, we like to keep our clients up-to-date with relevant news and key market insight.
News 2 weeks ago
Spotlight on… Rebecca Applin, Senior Regulatory Manager, Early Access Programs, Bionical Emas
News 2 months ago
Spotlight on… Matt Tutton, Pharmacovigilance Manager
News 3 months ago
Spotlight on… Alexander Santos, Vice President, Clinical Trial Supply US, Bionical Emas
News 4 months ago
Spotlight on… Nisha Vora, Senior Pharmacovigilance Project Manager, Bionical Emas
News 5 months ago
Spotlight on… Rakesh Davda, Head of Real World Data and Market Access, Bionical Emas